Immediate administration as emergency therapy for known or suspected opioid overdose

Active Ingredient: Naloxone

Indication for Naloxone

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Therapeutic intent: Curative procedure

Naloxone is intended for immediate administration as emergency therapy for known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression in both non-medical and healthcare settings.

Naloxone is indicated in adults and adolescents aged 14 years and over.

Naloxone is not a substitute for emergency medical care.

For this indication, competent medicine agencies globally authorize below treatments:

1.8 mg administered into one nostril

For:

Dosage regimens

In case that patient age in years is ≥ 14, nasal, 1.8 milligrams naloxone, 1 to 2 doses in total.

Detailed description

Adults and adolescents aged 14 years and over

The recommended dose is 1.8 mg administered into one nostril.

In some cases, further doses may be necessary. The appropriate maximum dose of naloxone is situation specific. If the patient does not respond, the second dose should be administered after 2-3 minutes. If the patient responds to the first administration but then relapses again into respiratory depression, the second dose should be administered immediately. Further doses (if available) should be administered in alternate nostrils and the patient should be monitored whilst awaiting arrival of the emergency services. Emergency services may administer further doses according to local guidelines.

Dosage considerations

Naloxone should be administered as soon as possible to avoid damage to the central nervous system or death.

Active ingredient

Naloxone

Naloxone hydrochloride, a semisynthetic morphine derivative (N-allyl-nor-oxymorphone), is a specific opioid antagonist that acts competitively at opioid receptors. It reveals very high affinity for the opioid receptor sites and therefore displaces both opioid agonists and partial antagonists, such as pentazocine, for example, but also nalorphine.

Read more about Naloxone

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.